GLOFITAMAB vs IMIQUIMOD: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLOFITAMAB vs IMIQUIMOD: Safety Overview
| Metric | GLOFITAMAB | IMIQUIMOD |
|---|---|---|
| Total FAERS Reports | 1,116 | 1,689 |
| Deaths Reported | 315 | 25 |
| Death Rate | 28.2% | 1.5% |
| Hospitalizations | 492 | 154 |
| Average Patient Age | 62.5 yrs | 62.3 yrs |
| % Female Patients | 53.2% | 52.1% |
| FDA Approval Date | N/A | Apr 15, 2011 |
| Manufacturer | Genentech, Inc. | Padagis Israel Pharmaceuticals Ltd |
| Route | INTRAVENOUS | TOPICAL |
| Marketing Status | N/A | Discontinued |